ARTICLE | Company News
Epigenomics, Companion Dx Reference Lab deal
June 25, 2012 7:00 AM UTC
Companion Dx Reference Lab received non-exclusive rights to use Epigenomics' septin 9 (SEPT9) biomarker to develop a blood-based, laboratory-developed test (LDT) to detect colorectal cancer. Epigenom...